Rapt Therapeutics (NASDAQ:RAPT) Lowered to Sell Rating by Wall Street Zen
Rapt Therapeutics (NASDAQ:RAPT – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other equities research analysts also recently weighed in on the company. HC Wainwright raised Rapt Therapeutics to a “strong-buy” rating and […]
